These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 27016021)
21. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice. Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780 [TBL] [Abstract][Full Text] [Related]
22. The novel NMDA receptor antagonist, 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, is a gating modifier in cultured mouse cortical neurons. Noh J; Lee ES; Chung JM J Neurochem; 2009 Jun; 109(5):1261-71. PubMed ID: 19302475 [TBL] [Abstract][Full Text] [Related]
23. Mercury-induced toxicity of rat cortical neurons is mediated through N-Methyl-D-Aspartate receptors. Xu F; Farkas S; Kortbeek S; Zhang FX; Chen L; Zamponi GW; Syed NI Mol Brain; 2012 Sep; 5():30. PubMed ID: 22980357 [TBL] [Abstract][Full Text] [Related]
24. Methylmercury-induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. Park ST; Lim KT; Chung YT; Kim SU Neurotoxicology; 1996; 17(1):37-45. PubMed ID: 8784817 [TBL] [Abstract][Full Text] [Related]
25. Protection by diphenyliodonium against glutamate neurotoxicity due to blocking of N-methyl-D-aspartate receptors. Nakamura Y; Tsuji K; Shuto M; Ogita K; Yoneda Y; Shimamoto K; Shibata T; Kataoka K Neuroscience; 1997 Jan; 76(2):459-66. PubMed ID: 9015330 [TBL] [Abstract][Full Text] [Related]
26. Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit. Matteucci A; Cammarota R; Paradisi S; Varano M; Balduzzi M; Leo L; Bellenchi GC; De Nuccio C; Carnovale-Scalzo G; Scorcia G; Frank C; Mallozzi C; Di Stasi AM; Visentin S; Malchiodi-Albedi F Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1070-7. PubMed ID: 20861489 [TBL] [Abstract][Full Text] [Related]
27. Chronic intermittent hypoxia induces NMDA receptor-dependent plasticity and suppresses nitric oxide signaling in the mouse hypothalamic paraventricular nucleus. Coleman CG; Wang G; Park L; Anrather J; Delagrammatikas GJ; Chan J; Zhou J; Iadecola C; Pickel VM J Neurosci; 2010 Sep; 30(36):12103-12. PubMed ID: 20826673 [TBL] [Abstract][Full Text] [Related]
28. Paliperidone Protects SH-SY5Y Cells Against MK-801-Induced Neuronal Damage Through Inhibition of Ca(2+) Influx and Regulation of SIRT1/miR-134 Signal Pathway. Zhu D; Zhang J; Wu J; Li G; Yao W; Hao J; Sun J Mol Neurobiol; 2016 May; 53(4):2498-509. PubMed ID: 26055227 [TBL] [Abstract][Full Text] [Related]
29. N-methyl-D-aspartate receptors amplify activation and aggregation of human platelets. Kalev-Zylinska ML; Green TN; Morel-Kopp MC; Sun PP; Park YE; Lasham A; During MJ; Ward CM Thromb Res; 2014 May; 133(5):837-47. PubMed ID: 24593912 [TBL] [Abstract][Full Text] [Related]
30. Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons. Doucet MV; O'Toole E; Connor T; Harkin A Neuroscience; 2015 Aug; 301():421-38. PubMed ID: 26071957 [TBL] [Abstract][Full Text] [Related]
31. Fast, non-competitive and reversible inhibition of NMDA-activated currents by 2-BFI confers neuroprotection. Han Z; Yang JL; Jiang SX; Hou ST; Zheng RY PLoS One; 2013; 8(5):e64894. PubMed ID: 23741413 [TBL] [Abstract][Full Text] [Related]
33. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
34. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine. Gilling KE; Jatzke C; Parsons CG Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186 [TBL] [Abstract][Full Text] [Related]
35. Glycine binding site of the synaptic NMDA receptor in subpostremal NTS neurons. Baptista V; Varanda WA J Neurophysiol; 2005 Jul; 94(1):147-52. PubMed ID: 15744010 [TBL] [Abstract][Full Text] [Related]
36. The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain. Manning SM; Boll G; Fitzgerald E; Selip DB; Volpe JJ; Jensen FE Int J Dev Neurosci; 2011 Nov; 29(7):767-73. PubMed ID: 21624454 [TBL] [Abstract][Full Text] [Related]
37. Promethazine inhibits NMDA-induced currents - new pharmacological aspects of an old drug. Adolph O; Köster S; Georgieff M; Georgieff EM; Moulig W; Föhr KJ Neuropharmacology; 2012 Aug; 63(2):280-91. PubMed ID: 22507664 [TBL] [Abstract][Full Text] [Related]
38. Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones. Wild AR; Akyol E; Brothwell SL; Kimkool P; Skepper JN; Gibb AJ; Jones S Neuropharmacology; 2013 Oct; 73():138-46. PubMed ID: 23727219 [TBL] [Abstract][Full Text] [Related]
39. The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Rammes G; Rupprecht R; Ferrari U; Zieglgänsberger W; Parsons CG Neurosci Lett; 2001 Jun; 306(1-2):81-4. PubMed ID: 11403963 [TBL] [Abstract][Full Text] [Related]
40. Altered NMDA receptor function in primary cultures of hippocampal neurons from mice lacking the Homer2 gene. Smothers CT; Szumlinski KK; Worley PF; Woodward JJ Synapse; 2016 Jan; 70(1):33-9. PubMed ID: 26426435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]